Lactose (India) Ltd | 162 Cr. | 129 | 247/84.3 | 36.9 | 46.7 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
MPS Pharmaa Ltd | 3.63 Cr. | 1.90 | 4.33/1.90 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
Gujarat Themis Biosyn Ltd | 4,163 Cr. | 382 | 411/192 | 93.3 | 22.8 | 0.18 % | 27.3 % | 21.7 % | 1.00 |
Gujarat Terce Laboratories Ltd | 29.7 Cr. | 40.0 | 94.9/37.2 | | 8.73 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 29.3 Cr. | 20.0 | 29.1/17.0 | 30.5 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
Godavari Drugs Ltd | 64.3 Cr. | 85.4 | 144/79.0 | 17.0 | 57.6 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
Glenmark Life Sciences Ltd | 59,511 Cr. | 2,108 | 2,286/1,275 | 44.6 | 314 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
Gennex Laboratories Ltd | 294 Cr. | 12.9 | 29.0/10.8 | 17.9 | 8.21 | 0.00 % | 12.5 % | 9.09 % | 1.00 |
Ganga Pharmaceuticals Ltd | 7.06 Cr. | 14.6 | 19.2/9.25 | 88.2 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
Fredun Pharmaceuticals Ltd | 588 Cr. | 1,244 | 1,340/635 | 25.1 | 299 | 0.06 % | 18.9 % | 15.8 % | 10.0 |
Fervent Synergies Ltd | 118 Cr. | 23.6 | 32.0/15.0 | 36.1 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
Fermenta Biotech Ltd | 1,008 Cr. | 342 | 449/219 | 9.65 | 123 | 0.73 % | 23.0 % | 24.9 % | 5.00 |
Fabino Enterprises Ltd | 5.35 Cr. | 25.5 | 39.0/22.8 | 41.2 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
Evoq Remedies Ltd | 8.91 Cr. | 3.58 | 9.28/2.11 | 99.0 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
Everest Organics Ltd | 400 Cr. | 412 | 477/112 | 64.4 | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
Entero Healthcare Solutions Ltd | 4,998 Cr. | 1,148 | 1,584/1,078 | 48.7 | 396 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
Murae Organisor Ltd | 143 Cr. | 0.70 | 1.24/0.48 | 9.42 | 1.02 | 0.00 % | 4.21 % | 5.69 % | 1.00 |
Dipna Pharmachem Ltd | 48.1 Cr. | 20.0 | 26.3/6.40 | 49.6 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
Decipher Labs Ltd | 10.7 Cr. | 10.6 | 17.9/9.61 | | 22.6 | 0.00 % | 28.4 % | 22.7 % | 10.0 |
Coral Laboratories Ltd | 191 Cr. | 535 | 961/443 | 10.4 | 563 | 0.28 % | 17.4 % | 13.1 % | 10.0 |
Concord Drugs Ltd | 67.2 Cr. | 67.2 | 71.0/26.1 | 172 | 34.1 | 0.00 % | 4.83 % | 0.88 % | 10.0 |
Colinz Laboratories Ltd | 19.4 Cr. | 42.4 | 88.7/37.9 | 40.4 | 20.7 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
Cian Healthcare Ltd | 10.6 Cr. | 4.26 | 5.66/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 17.8 Cr. | 119 | 154/59.6 | | 87.6 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
Checkpoint Trends Ltd | 24.7 Cr. | 45.2 | 45.4/9.11 | 275 | 1.02 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
Chandra Bhagat Pharma Ltd | 37.0 Cr. | 49.0 | 80.0/0.00 | 52.1 | 39.7 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
Brawn Biotech Ltd | 7.12 Cr. | 23.7 | 26.0/15.5 | | 11.2 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
Blue Jet Healthcare Ltd | 11,844 Cr. | 683 | 1,028/464 | 33.0 | 65.3 | 0.18 % | 39.8 % | 30.2 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 94.8 Cr. | 22.0 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 12.0 Cr. | 23.6 | 46.0/17.4 | 52.0 | 18.7 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
BDH Industries Ltd | 244 Cr. | 424 | 429/241 | 25.6 | 119 | 1.06 % | 17.8 % | 14.2 % | 10.0 |
Bacil Pharma Ltd | 52.1 Cr. | 36.3 | 62.6/25.1 | 46.9 | 17.7 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
Aurobindo Pharma Ltd | 66,113 Cr. | 1,129 | 1,560/994 | 19.5 | 557 | 0.40 % | 14.2 % | 11.1 % | 1.00 |
Auro Laboratories Ltd | 150 Cr. | 240 | 303/170 | 217 | 69.0 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
Anuh Pharma Ltd | 875 Cr. | 87.3 | 123/74.0 | 19.0 | 32.5 | 1.72 % | 17.2 % | 13.4 % | 5.00 |
ANG Lifesciences India Ltd | 49.4 Cr. | 37.8 | 56.8/21.0 | | 51.2 | 0.00 % | 4.12 % | 14.4 % | 10.0 |
Acutaas Chemicals Ltd | 12,073 Cr. | 1,475 | 1,530/727 | 63.9 | 160 | 0.10 % | 19.9 % | 16.0 % | 5.00 |
Amerise Biosciences Ltd | 4.89 Cr. | 0.74 | 1.45/0.66 | 97.8 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 236 Cr. | 30.8 | 68.0/30.0 | 12.6 | 18.3 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
Adline Chem Lab Ltd | 10.5 Cr. | 18.0 | 26.0/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 130 Cr. | 5.54 | 6.25/2.82 | 237 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
Abbott India Ltd | 65,687 Cr. | 30,890 | 37,000/25,260 | 45.2 | 1,992 | 1.54 % | 46.2 % | 35.7 % | 10.0 |
Aarti Pharmalabs Ltd | 8,159 Cr. | 900 | 972/550 | 30.6 | 220 | 0.56 % | 17.4 % | 14.5 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 209 Cr. | 74.2 | 75.7/31.3 | 50.3 | 48.8 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
Zota Health Care Ltd | 4,465 Cr. | 1,473 | 1,555/535 | | 78.1 | 0.07 % | 17.0 % | 36.0 % | 10.0 |
Wockhardt Ltd | 24,784 Cr. | 1,526 | 1,870/915 | | 268 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
Wanbury Ltd | 853 Cr. | 259 | 330/154 | 19.8 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.11 % | % | 2.00 |
Venus Remedies Ltd | 579 Cr. | 436 | 568/270 | 12.4 | 420 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
Unichem Laboratories Ltd | 3,582 Cr. | 507 | 950/483 | 28.7 | 348 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
TTK Healthcare Ltd | 1,622 Cr. | 1,173 | 1,770/991 | 24.1 | 754 | 0.85 % | 9.26 % | 6.89 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,20,892 Cr. | 3,567 | 3,790/2,886 | 59.9 | 224 | 0.90 % | 27.0 % | 26.5 % | 5.00 |
Themis Medicare Ltd | 1,209 Cr. | 132 | 317/98.0 | | 43.7 | 0.38 % | 10.4 % | 7.65 % | 1.00 |
Syncom Formulations (India) Ltd | 1,697 Cr. | 18.1 | 24.0/14.1 | 29.8 | 3.62 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
Cohance Lifesciences Ltd | 34,868 Cr. | 913 | 1,360/856 | 99.2 | 66.6 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
Suven Life Sciences Ltd | 4,983 Cr. | 219 | 303/102 | | 5.04 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 3,95,542 Cr. | 1,649 | 1,960/1,553 | 34.5 | 301 | 0.97 % | 20.2 % | 16.9 % | 1.00 |
Solara Active Pharma Sciences Ltd | 3,054 Cr. | 686 | 886/441 | 125 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
SMS Pharmaceuticals Ltd | 2,528 Cr. | 285 | 398/175 | 36.0 | 75.9 | 0.14 % | 12.2 % | 11.0 % | 1.00 |
SMS Lifesciences India Ltd | 373 Cr. | 1,224 | 1,690/956 | 21.6 | 650 | 0.12 % | 11.8 % | 10.8 % | 10.0 |
Shilpa Medicare Ltd | 8,002 Cr. | 818 | 1,003/530 | 62.2 | 243 | 0.12 % | 7.82 % | 4.21 % | 1.00 |
Sequent Scientific Ltd | 5,004 Cr. | 199 | 241/111 | 166 | 28.1 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
Sanofi India Ltd | 11,598 Cr. | 5,037 | 7,400/4,146 | 32.5 | 340 | 2.32 % | 49.2 % | 47.2 % | 10.0 |
RPG Life Sciences Ltd | 3,961 Cr. | 2,395 | 2,977/1,772 | 38.2 | 321 | 0.84 % | 32.8 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 10,412 Cr. | 6,266 | 6,739/4,863 | 34.6 | 323 | 2.00 % | 47.8 % | 36.4 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 195 Cr. | 55.3 | 87.5/31.9 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
Pfizer Ltd | 23,749 Cr. | 5,192 | 6,039/3,701 | 35.1 | 922 | 0.67 % | 21.6 % | 16.4 % | 10.0 |
Par Drugs & Chemicals Ltd | 146 Cr. | 119 | 348/81.0 | 10.3 | 80.4 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
Panacea Biotec Ltd | 2,726 Cr. | 446 | 582/259 | | 136 | 0.00 % | 4.68 % | 5.03 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 3,648 Cr. | 717 | 1,998/604 | 42.8 | 250 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
Neuland Laboratories Ltd | 20,381 Cr. | 15,873 | 18,100/10,060 | 155 | 1,188 | 0.08 % | 18.7 % | 14.8 % | 10.0 |
Nectar Lifescience Ltd | 365 Cr. | 16.3 | 48.4/13.0 | | 42.6 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
Natco Pharma Ltd | 15,834 Cr. | 884 | 1,564/660 | 9.33 | 425 | 0.68 % | 32.8 % | 28.0 % | 2.00 |
Morepen Laboratories Ltd | 2,958 Cr. | 54.0 | 94.5/41.7 | 31.9 | 21.1 | 0.37 % | 15.1 % | 11.8 % | 2.00 |
Marksans Pharma Ltd | 8,080 Cr. | 178 | 359/165 | 23.1 | 54.4 | 0.45 % | 20.0 % | 16.8 % | 1.00 |
Mangalam Drugs and Organics Ltd | 119 Cr. | 75.0 | 142/65.5 | | 93.9 | 0.00 % | 8.20 % | 4.76 % | 10.0 |
Lyka Labs Ltd | 356 Cr. | 99.8 | 177/90.2 | 47.5 | 29.0 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
Lupin Ltd | 93,482 Cr. | 2,047 | 2,403/1,774 | 25.3 | 377 | 0.59 % | 21.3 % | 20.6 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,110 Cr. | 553 | 980/499 | 12.8 | 335 | 0.33 % | 17.6 % | 13.0 % | 10.0 |
Laurus Labs Ltd | 49,864 Cr. | 923 | 926/423 | 97.9 | 84.6 | 0.13 % | 9.47 % | 7.75 % | 2.00 |
Kwality Pharmaceuticals Ltd | 1,027 Cr. | 989 | 1,235/596 | 23.6 | 256 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 171 Cr. | 78.7 | 129/63.6 | | 67.8 | 0.00 % | 30.1 % | % | 10.0 |
Kopran Ltd | 835 Cr. | 173 | 357/154 | 23.9 | 107 | 1.74 % | 9.75 % | 7.64 % | 10.0 |
Kilitch Drugs (India) Ltd | 633 Cr. | 364 | 500/265 | 22.6 | 116 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
Jubilant Pharmova Ltd | 17,787 Cr. | 1,115 | 1,310/802 | 36.6 | 393 | 0.45 % | 9.54 % | 9.55 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 26,457 Cr. | 1,691 | 1,998/1,303 | 38.6 | 221 | 0.92 % | 25.8 % | 20.1 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,620 Cr. | 243 | 328/152 | 38.0 | 36.1 | 1.03 % | 23.0 % | 18.6 % | 2.00 |
Ipca Laboratories Ltd | 34,001 Cr. | 1,341 | 1,758/1,168 | 38.0 | 274 | 0.30 % | 14.7 % | 12.8 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 3,485 Cr. | 119 | 123/57.5 | 33.1 | 57.5 | 0.67 % | 8.86 % | 6.13 % | 2.00 |
Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 774 Cr. | 106 | 144/67.2 | 35.1 | 194 | 0.00 % | 3.47 % | 3.50 % | 10.0 |
Indoco Remedies Ltd | 2,784 Cr. | 302 | 384/190 | | 111 | 0.07 % | 0.49 % | 7.02 % | 2.00 |
Hikal Ltd | 3,359 Cr. | 272 | 465/245 | 53.0 | 102 | 0.51 % | 9.85 % | 7.38 % | 2.00 |
Hester Biosciences Ltd | 1,745 Cr. | 2,052 | 2,786/1,243 | 46.4 | 369 | 0.34 % | 9.71 % | 9.18 % | 10.0 |
Gufic BioSciences Ltd | 3,645 Cr. | 364 | 504/285 | 59.6 | 60.0 | 0.03 % | 13.0 % | 12.3 % | 1.00 |
Granules India Ltd | 13,315 Cr. | 549 | 628/412 | 27.9 | 153 | 0.27 % | 15.1 % | 13.9 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 58,012 Cr. | 2,056 | 2,286/1,275 | 43.5 | 314 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 46,399 Cr. | 2,739 | 3,516/1,921 | 49.0 | 115 | 1.54 % | 63.2 % | 46.9 % | 10.0 |
Gland Pharma Ltd | 32,735 Cr. | 1,987 | 2,131/1,200 | 28.8 | 592 | 0.91 % | 15.8 % | 11.6 % | 1.00 |
FDC Ltd | 7,650 Cr. | 470 | 583/359 | 28.4 | 140 | 1.06 % | 15.9 % | 11.8 % | 1.00 |
ERIS Lifesciences Ltd | 22,203 Cr. | 1,630 | 1,910/1,097 | 57.4 | 210 | 0.46 % | 12.2 % | 12.9 % | 1.00 |
Dr Reddys Laboratories Ltd | 1,09,425 Cr. | 1,311 | 1,406/1,020 | 19.3 | 402 | 0.61 % | 22.7 % | 18.0 % | 1.00 |
Dishman Carbogen Amcis Ltd | 4,373 Cr. | 279 | 308/161 | 36.8 | 372 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
Cipla Ltd | 1,25,949 Cr. | 1,559 | 1,702/1,310 | 23.4 | 386 | 0.83 % | 22.7 % | 17.8 % | 2.00 |
Caplin Point Laboratories Ltd | 17,588 Cr. | 2,315 | 2,641/1,551 | 31.1 | 375 | 0.26 % | 25.8 % | 21.7 % | 2.00 |
Brooks Laboratories Ltd | 442 Cr. | 149 | 203/95.6 | 218 | 33.3 | 0.00 % | 9.90 % | 12.2 % | 10.0 |
Bliss GVS Pharma Ltd | 1,625 Cr. | 154 | 191/105 | 15.2 | 99.7 | 0.33 % | 11.7 % | 8.36 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 71.1 Cr. | 43.6 | 86.2/40.4 | 25.5 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
Biocon Ltd | 49,240 Cr. | 368 | 406/291 | 136 | 180 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
Beta Drugs Ltd | 1,864 Cr. | 1,847 | 2,215/1,430 | 40.7 | 195 | 0.00 % | 27.3 % | 25.8 % | 10.0 |
Bal Pharma Ltd | 136 Cr. | 85.0 | 141/76.3 | 19.0 | 48.6 | 1.42 % | 10.1 % | 9.66 % | 10.0 |
Bafna Pharmaceuticals Ltd | 311 Cr. | 131 | 132/67.8 | 30.9 | 35.8 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
Astrazeneca Pharma India Ltd | 22,722 Cr. | 9,090 | 10,691/6,220 | 107 | 308 | 0.35 % | 33.4 % | 23.6 % | 2.00 |
Amrutanjan Health Care Ltd | 2,154 Cr. | 747 | 843/544 | 39.5 | 113 | 0.61 % | 22.4 % | 16.5 % | 1.00 |
Alpa Laboratories Ltd | 198 Cr. | 93.8 | 145/85.0 | 7.50 | 86.4 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
Alkem Laboratories Ltd | 65,489 Cr. | 5,480 | 6,376/4,492 | 28.8 | 1,002 | 0.82 % | 20.4 % | 19.4 % | 2.00 |
Alembic Pharmaceuticals Ltd | 18,818 Cr. | 957 | 1,304/725 | 31.7 | 264 | 1.15 % | 13.0 % | 11.4 % | 2.00 |
Albert David Ltd | 462 Cr. | 809 | 1,540/763 | 73.4 | 688 | 0.62 % | 6.45 % | 4.39 % | 10.0 |
Ajanta Pharma Ltd | 31,849 Cr. | 2,550 | 3,464/2,022 | 34.2 | 303 | 1.10 % | 32.4 % | 24.9 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,788 Cr. | 338 | 550/258 | 27.7 | 127 | 1.54 % | 13.1 % | 9.54 % | 2.00 |
Aarti Drugs Limited | 4,749 Cr. | 516 | 575/312 | 26.5 | 136 | 0.19 % | 13.5 % | 13.0 % | 10.0 |
Industry Average | 19,168.08 Cr | 1,200.86 | | 51.43 | 193.71 | 0.32% | 16.38% | 15.10% | 6.18 |